Dunedin, New Zealand

Natalie June Medlicott

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Natalie June Medlicott

Introduction

Natalie June Medlicott is a prominent inventor based in Dunedin, New Zealand. She has made significant contributions to the field of pharmaceuticals, particularly in the development of extended release formulations. With a total of 10 patents to her name, Medlicott's work focuses on addressing complex mental health issues.

Latest Patents

Among her latest patents is an oral extended release pharmaceutical formulation designed for the treatment of treatment-resistant depression, treatment-resistant anxiety, and phobia. This innovative formulation aims to provide patients with more effective treatment options for their mental health challenges.

Career Highlights

Throughout her career, Medlicott has worked with notable companies, including Douglas Pharmaceuticals Limited and Douglas Pharmaceuticals Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to the advancement of pharmaceutical science.

Collaborations

Medlicott has collaborated with esteemed colleagues such as Paul William Glue and Peter William Surman. These partnerships have further enriched her research and development efforts in the pharmaceutical industry.

Conclusion

Natalie June Medlicott's innovative work in pharmaceutical formulations highlights her dedication to improving mental health treatment. Her contributions continue to make a significant impact in the field, showcasing the importance of innovation in addressing complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…